Medicine-Gen Internal Med

MEMPHIS TN 381632116
Tel: (901) 448-6820


  1. Adams-Graves, P, Ostric, EJ, Martin, M, Richardson, P, Lewis, JB. Sickle cell hospital unit: a disease-specific model. J Healthc Manag, 53 (5), 305-15; discussion 316-7, 2008.
  2. Adams-Graves, P, Lamar, K, Johnson, C, Corley, P. Development and validation of SIMS: an instrument for measuring quality of life of adults with sickle cell disease. Am J Hematol, 83 (7), 558-62, 2008.
  3. Ataga, KI, Smith, WR, De Castro, LM, Swerdlow, P, Saunthararajah, Y, Castro, O, Vichinsky, E, Kutlar, A, Orringer, EP, Rigdon, GC, Stocker, JW, ,. Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood, 111 (8), 3991-7, 2008.
  4. Jeng, MR, Adams-Graves, P, Howard, TA, Whorton, MR, Li, CS, Ware, RE. Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease. Am J Hematol, 74 (4), 243-8, 2003.
  5. Orringer, EP, Casella, JF, Ataga, KI, Koshy, M, Adams-Graves, P, Luchtman-Jones, L, Wun, T, Watanabe, M, Shafer, F, Kutlar, A, Abboud, M, Steinberg, M, Adler, B, Swerdlow, P, Terregino, C, Saccente, S, Files, B, Ballas, S, Brown, R, Wojtowicz-Praga, S, Grindel, JM. Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial. JAMA, 286 (17), 2099-106, 2001.
  6. Adams-Graves, P, Kedar, A, Koshy, M, Steinberg, M, Veith, R, Ward, D, Crawford, R, Edwards, S, Bustrack, J, Emanuele, M. RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: a pilot study. Blood, 90 (5), 2041-6, 1997.
  7. Adams-Graves, P, Heltsley, C, Deitcher, S. Hydroxyurea in sickle cell disease. N Engl J Med, 334 (5), 333-4, 1996.
  8. Sandoval, C, Parganas, E, Wang, W, Ihle, JN, Adams-Graves, P. Lack of alterations in the cytoplasmic domains of the granulocyte colony-stimulating factor receptors in eight cases of severe congenital neutropenia. Blood, 85 (3), 852-3, 1995.